Details for New Drug Application (NDA): 010401
✉ Email this page to a colleague
NDA 010401 describes MYSOLINE, which is a drug marketed by Fhta and Valeant and is included in two NDAs. It is available from one supplier. Additional details are available on the MYSOLINE profile page.
The generic ingredient in MYSOLINE is primidone. There are seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the primidone profile page.
The generic ingredient in MYSOLINE is primidone. There are seven drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the primidone profile page.
Medical Subject Heading (MeSH) Categories for 010401
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SUSPENSION;ORAL | Strength | 250MG/5ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
